Research Highlights

Antidepressant not working? AI may do a better job than your doctor in matching you with the best medicine

Professor John Cantiello reviews the literature to find out who is cheating, how, and how to head it off

George Mason University’s Health and Public Safety Workforce Resiliency Program supports the health care workforce through free online training modules 

George Mason University Launches Major Biobank to Advance Maternal and Child Health Research

The program offers tuition coverage and stipends to allow graduate students to advance their research without worrying about funding their work through outside sources.

This research is focused on smoking cessation particularly for Virginia youth and is funded in part by a Virginia Foundation for Healthy Youth grant

NIH grant to fund depression chatbot for Black patients

Professor Farrokh Alemi receives NIH grant to pilot first-of-its-kind, evidence-based artificial intelligence tool to address the medication needs of Black and African American people with depression. This is part of the college’s Innovate for Good story series. 

Gimm, a Health Administration and Policy faculty member, and Inoue, a Social Work faculty member, have both contributed significant research to support healthy aging and improve the well-being of older adults and family caregivers.  

Our eyes are more frequently on screens than on human faces.

George Mason researchers harness the power of artificial intelligence to match patients with the most effective antidepressant for their unique needs.

MeAgainMeds.com, a free AI-powered website, helps clinicians more effectively match patients with the optimal antidepressant using big data.